Trial Search Results

Preimplantation Genetic Testing in Women of Advanced Maternal Age

The GETSET trial is a prospective randomized trial designed to evaluate the clinical outcomes of incorporating preimplantation genetic testing for aneuploidies (PGT-A) in elective single embryo transfer in women between 35 and 40 years of age.

Stanford is currently not accepting patients for this trial.

Lead Sponsor:

Genomic Prediction Inc.

Stanford Investigator(s):

Intervention(s):

  • Procedure: Preimplantation genetic testing for aneuploidy (PGT-A)

Phase:

N/A

Eligibility


Inclusion Criteria:

   - Women undergoing IVF of between 35 and 40 years of age at IVF cycle start

   - Utilization of Intracytoplasmic Sperm Injection ICSI

   - Utilization of ejaculated or testicular sperm

   - Utilization of autologous or donor sperm

   - All Controlled Ovarian Hyperstimulation (COH) protocols

Exclusion criteria:

   - Patients with anovulatory Polycystic ovarian syndrome (PCOS)

   - Utilization of donor oocytes

   - Utilization of gestational carrier

   - Recurrent Pregnancy Loss (RPL) defined as ≥ 3 consecutive miscarriages

   - Recurrent Implantation Failure (RIF) defined as ≥ 3 more failed embryo transfers

Ages Eligible for Study

35 Years - 40 Years

Genders Eligible for Study

Female

Not currently accepting new patients for this trial

Contact Information

Stanford University
School of Medicine
300 Pasteur Drive
Stanford, CA 94305
Ruth B Lathi, MD
6504987911
Not Recruiting